{"id":24923,"date":"2022-10-06T12:00:00","date_gmt":"2022-10-06T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/"},"modified":"2022-10-06T12:00:00","modified_gmt":"2022-10-06T12:00:00","slug":"verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/","title":{"rendered":"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1938 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Astma, chronische rhinosinusitis met neuspoliepen of CRSwNP en atopische dermatitis zijn drie chronische aandoeningen die vaak gelijktijdig voorkomen bij pati\u00ebnten. Ze kunnen een groot aantal symptomen veroorzaken, vari\u00ebrend van mild tot ernstig. In het gunstigste geval zijn ze irriterend. In het slechtste geval be\u00efnvloeden ze de kwaliteit van leven van pati\u00ebnten ingrijpend. Deze drie chronische aandoeningen zijn verbonden door een gemeenschappelijke pathogenese genaamd type 2-inflammatie.    <\/p>\n<p>Wat is het? Waarom is het relevant? Wat weten we erover? En hoe verbeteren we het leven van deze pati\u00ebnten?   <\/p>\n<ul>\n<li>Deel 1: <a href=\"https:\/\/youtu.be\/9mS2cp3Ar8A\" target=\"_blank\" rel=\"noopener\">Wat is type 2-inflammatie?<\/a><\/li>\n<li>Deel 2: <a href=\"https:\/\/youtu.be\/06pcLM6vbw0\" target=\"_blank\" rel=\"noopener\">Wat zijn de huidige tekortkomingen in de zorg?<\/a><\/li>\n<li>Deel 3: <a href=\"https:\/\/youtu.be\/JIYC-jXkDos\" target=\"_blank\" rel=\"noopener\">Ambities om de interdisciplinaire zorg te verbeteren<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1939 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-videospeler\" src=\"https:\/\/www.youtube.com\/embed\/oJT-SDsuiw4?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1946 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<h3 class=\"paragraph__title\">Dit Innovation Forum wordt ondersteund door:<\/h3>\n<div class=\"text__text text text--paragraph\">\n<p><a href=\"https:\/\/www.sanofi.com\/en\/your-health\/specialty-care\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"align-left\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sanofi-Regeneron_0.png\" alt=\"Sanofi Regeneron\" width=\"258\" height=\"172\" data-entity-type=\"file\" data-entity-uuid=\"e6811aeb-3761-40dc-b6ff-ab2d1131aacf\"><\/a><a href=\"https:\/\/www.gsk.com\/en-gb\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"align-left\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/GSK_2.png\" alt=\"GSK\" width=\"262\" height=\"174\" data-entity-type=\"file\" data-entity-uuid=\"12cdb561-4f1a-4b39-876a-95b461050fd5\"><\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Astma, chronische rhinosinusitis met neuspoliepen of CRSwNP en atopische dermatitis zijn drie chronische aandoeningen die vaak gelijktijdig voorkomen bij pati\u00ebnten. Ze kunnen een groot aantal symptomen veroorzaken, vari\u00ebrend van mild tot ernstig. In het gunstigste geval zijn ze irriterend. In het slechtste geval be\u00efnvloeden ze de kwaliteit van leven van pati\u00ebnten ingrijpend. Deze drie chronische aandoeningen zijn verbonden door een gemeenschappelijke pathogenese genaamd type 2-inflammatie. Wat is het? Waarom is het relevant? Wat weten we erover? En hoe verbeteren we het leven van deze pati\u00ebnten? Deel 1: Wat is type 2-inflammatie? Deel 2: Wat zijn de huidige tekortkomingen in de zorg? Deel 3: Ambities om de interdisciplinaire zorg te verbeteren Dit Innovation Forum wordt ondersteund door:<\/p>\n","protected":false},"author":1,"featured_media":24940,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[257],"tags":[235,258,259],"class_list":["post-24923","news","type-news","status-publish","has-post-thumbnail","hentry","category-innovation-forum-debates","tag-debatten","tag-innovation-forum","tag-type-2-inflammatie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie\" \/>\n<meta property=\"og:description\" content=\"Astma, chronische rhinosinusitis met neuspoliepen of CRSwNP en atopische dermatitis zijn drie chronische aandoeningen die vaak gelijktijdig voorkomen bij pati\u00ebnten. Ze kunnen een groot aantal symptomen veroorzaken, vari\u00ebrend van mild tot ernstig. In het gunstigste geval zijn ze irriterend. In het slechtste geval be\u00efnvloeden ze de kwaliteit van leven van pati\u00ebnten ingrijpend. Deze drie chronische aandoeningen zijn verbonden door een gemeenschappelijke pathogenese genaamd type 2-inflammatie. Wat is het? Waarom is het relevant? Wat weten we erover? En hoe verbeteren we het leven van deze pati\u00ebnten? Deel 1: Wat is type 2-inflammatie? Deel 2: Wat zijn de huidige tekortkomingen in de zorg? Deel 3: Ambities om de interdisciplinaire zorg te verbeteren Dit Innovation Forum wordt ondersteund door:\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sanofi-Regeneron_0.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/\",\"name\":\"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png\",\"datePublished\":\"2022-10-06T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png\",\"width\":427,\"height\":280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/","og_locale":"nl_NL","og_type":"article","og_title":"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie","og_description":"Astma, chronische rhinosinusitis met neuspoliepen of CRSwNP en atopische dermatitis zijn drie chronische aandoeningen die vaak gelijktijdig voorkomen bij pati\u00ebnten. Ze kunnen een groot aantal symptomen veroorzaken, vari\u00ebrend van mild tot ernstig. In het gunstigste geval zijn ze irriterend. In het slechtste geval be\u00efnvloeden ze de kwaliteit van leven van pati\u00ebnten ingrijpend. Deze drie chronische aandoeningen zijn verbonden door een gemeenschappelijke pathogenese genaamd type 2-inflammatie. Wat is het? Waarom is het relevant? Wat weten we erover? En hoe verbeteren we het leven van deze pati\u00ebnten? Deel 1: Wat is type 2-inflammatie? Deel 2: Wat zijn de huidige tekortkomingen in de zorg? Deel 3: Ambities om de interdisciplinaire zorg te verbeteren Dit Innovation Forum wordt ondersteund door:","og_url":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sanofi-Regeneron_0.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/","url":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/","name":"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png","datePublished":"2022-10-06T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png","width":427,"height":280},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/verbeterde-coordinatie-van-de-zorg-bij-type-2-inflammatie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/nl\/news\/"},{"@type":"ListItem","position":3,"name":"Verbeterde co\u00f6rdinatie van de zorg bij type 2-inflammatie"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/nl\/#website","url":"https:\/\/www.euforea.org\/nl\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/nl\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/24923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=24923"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/24923\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/24940"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=24923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=24923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=24923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}